Division of Preventive and Behavioral Medicine, Department of Medicine; UMass Worcester Prevention Research Center
Dermatology | Health Policy | Public Health
Tanning bed use, particularly among teen girls and young adult women, has become a modern-day epidemic in the past 20 years. Numerous studies have established the link between indoor tanning use and skin cancer, including melanoma. Reducing the harms of indoor tanning is one of 5 goals outlined in the 2014 US Surgeon General’s “Call to Action to Prevent Skin Cancer.”Consistent with the Call to Action, on December 22, 2015, the US Food and Drug Administration (FDA) issued a proposed rule with the following restrictions for sunlamp products (ie, indoor tanning beds and booths): (1) to ban their use among individuals younger than 18 years; (2) to require prospective users to sign a risk acknowledgment certification; and (3) to provide user manuals to customers and tanning facility operators on request.
Rights and Permissions
Publisher PDF posted after 12 months as allowed by the publisher's author rights policy at http://jamanetwork.com/journals/jamadermatology/pages/instructions-for-authors#SecDepositingResearchArticlesinApprovedPublicRepositories. Citation: JAMA Dermatol. 2016 May 1;152(5):509-10. doi: 10.1001/jamadermatol.2016.0504. Link to article on publisher's site
indoor tanning, FDA, regulation
Coups, Elliot J.; Geller, Alan C.; and Pagoto, Sherry L., "The US Food and Drug Administration's Proposed Rule to Increase Regulation of Indoor Tanning Devices" (2016). University of Massachusetts Medical School Faculty Publications. 1123.